Market starts off 2023 with a bang, rebounds for winning week. Plus, a new Alzheimer’s drug approval. 1/6/23

Market starts off 2023 with a bang, rebounds for winning week. Plus, a new Alzheimer’s drug approval. 1/6/23

  • Af
  • Episode
    • 1281
  • Published
    • 6. jan. 2023
  • Forlag
0 Anmeldelser
0
Episode
1281 of 2000
Længde
22M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

Stocks rally Friday after a seemingly ‘goldilocks’ jobs report, with consumer-leveraged stocks among the biggest winners. Plus, an exclusive with the EISAI US CEO - which worked with Biogen on the FDA’s approval of its Alzheimer’s treatment that slowed cognitive decline in a clinical trial. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for Market starts off 2023 with a bang, rebounds for winning week. Plus, a new Alzheimer’s drug approval. 1/6/23

Other podcasts you might like ...